Narconon is an international drug rehabilitation, prevention and education organization that has been operating for over five decades, with a mission to provide a different and drug-free approach to rehabilitation. With over 100 centers worldwide, Narconon has a strong track record, with seven out of ten graduates of their residential program successfully maintaining sobriety upon returning home.
Founded in 1966, Narconon has made a significant impact, reaching millions of individuals with a drug-free message and helping tens of thousands find a new lease on a sober life. Their commitment is grounded in the belief that a truly drug-free life is achievable and that individuals can return to their families and communities as productive, addiction-free members of society.
As a Health Care organization based in the United States, Narconon's dedication to saving lives and families is commendable. Although details on their last investment and investors are not available at this time, their long-standing presence and impact in the drug rehabilitation space make them a noteworthy organization for potential venture capital consideration.